<DOC>
	<DOCNO>NCT00233363</DOCNO>
	<brief_summary>The purpose study exploratively investigate clinical efficacy rebamipide dry mouth patient Sjögren ’ syndrome comparison placebo .</brief_summary>
	<brief_title>Exploratory Study Dry Mouth Patients With Sjögren ’ Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Xerostomia</mesh_term>
	<mesh_term>Sjogren 's Syndrome</mesh_term>
	<mesh_term>Rebamipide</mesh_term>
	<criteria>1 . Patients Sjögren ’ syndrome ( Revised Japanese criterion Sjögren ’ syndrome ( 1999 ) : 1998 research report immunological intractable disease specify Japanese Ministry Health Welfare ) 2 . Patients age 20 year old time consent 3 . Patients dry mouth 4 . Patients decrease salivation 1 . Patients develop dry mouth clearly due cause Sjögren ’ syndrome 2 . Patients Saxon test perform ( artificial tooth , tooth implant , etc . ) 3 . Patients receive rebamipide within 3 month prior obtain inform consent 4 . Patients pregnant , possibly pregnant , lactate 5 . Patients history hypersensitivity rebamipide 6 . Patients receive investigational drug within 3 month prior obtain inform consent 7 . Patients otherwise judged inappropriate inclusion study investigator subinvestigator</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2007</verification_date>
</DOC>